# Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin

> **NCT00410033** · NA · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 74 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** soluble human insulin
- **DRUG:** isophane human insulin
- **DRUG:** insulin aspart

## Key facts

- **NCT ID:** NCT00410033
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1989-12
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2016-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00410033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00410033, "Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00410033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*